In an adult with hyperglycemia, how do I differentiate Cushing syndrome from type 2 diabetes mellitus and what are the recommended diagnostic tests and treatment strategies for each condition?

Differentiating Cushing Syndrome from Type 2 Diabetes in Adults with Hyperglycemia

In adults with hyperglycemia, screen for Cushing syndrome using the 1-mg overnight dexamethasone suppression test (DST) if the patient has poorly controlled type 2 diabetes (HbA1c ≥8%) despite multiple glucose-lowering agents, especially when combined with hypertension, obesity, and microvascular complications.

Clinical Differentiation Strategy

Key Clinical Features That Suggest Cushing Syndrome Over Simple Type 2 Diabetes

Look specifically for these discriminating features that point toward hypercortisolism 1:

• Facial features: Moon facies, facial plethora, supraclavicular fat pads, dorsocervical fat pad ("buffalo hump")
• Skin changes: Purple striae (>1 cm wide), thin skin with easy bruising, poor wound healing
• Body composition: Central obesity with proximal muscle weakness and wasting
• Bone manifestations: Vertebral fractures (occur in 30-50% of Cushing patients), osteoporosis at young age
• Cardiovascular: Severe or treatment-resistant hypertension, left ventricular hypertrophy
• Metabolic: Diabetes that develops rapidly or is difficult to control despite appropriate therapy

Critical distinction: Type 2 diabetes typically presents with gradual hyperglycemia and family history of diabetes 2, while Cushing-associated diabetes often presents with rapid onset, poor glycemic control despite multiple agents, and the characteristic physical stigmata listed above.

Diagnostic Testing Algorithm

Step 1: Initial Screening for Cushing Syndrome

Who to screen 3, 4, 5:

• Type 2 diabetes patients with HbA1c ≥8% despite appropriate treatment
• Presence of hypertension requiring treatment
• Obesity (particularly central/visceral)
• Microvascular complications (retinopathy, nephropathy, neuropathy)
• Young age at diabetes onset with rapid progression

Screening test of choice: 1-mg overnight dexamethasone suppression test 6, 5

• Administer 1 mg dexamethasone orally at 11 PM-midnight
• Measure serum cortisol at 8 AM the next morning
• Interpretation: Cortisol <50 nmol/L (1.8 μg/dL) excludes Cushing syndrome
• Positive screen: Cortisol ≥50 nmol/L requires further evaluation

Step 2: Confirmatory Testing (if screening positive)

If 1-mg DST is abnormal 3, 4:

1. Repeat the 1-mg DST after 3-6 months to confirm persistence
2. Perform 2-day, 2-mg dexamethasone suppression test
   • Give 0.5 mg dexamethasone every 6 hours for 48 hours
   • Measure cortisol 6 hours after last dose
   • Diagnosis confirmed: Cortisol ≥50 nmol/L (1.8 μg/dL)
3. Add midnight serum cortisol (≥7.5 μg/dL supports diagnosis) 3
4. Consider 24-hour urinary free cortisol (UFC) to assess severity

Important caveat: False positives occur in 3.7-21% of diabetic patients 5. Causes include:

• Inadequate glycemic control at time of testing
• Acute illness or stress
• Medications (estrogens, anticonvulsants)
• Pseudo-Cushing states (depression, alcoholism)

Step 3: Localization Studies (once biochemically confirmed)

After confirming hypercortisolism, determine the source:

• Pituitary MRI for Cushing disease
• Adrenal CT for adrenal adenoma/carcinoma
• ACTH levels to differentiate ACTH-dependent vs. independent causes

Prevalence Data to Guide Clinical Suspicion

The prevalence of unsuspected Cushing syndrome varies by patient selection 3, 4, 7, 5:

• Unselected type 2 diabetes patients: 0.6-2% 4
• Poorly controlled diabetes (HbA1c ≥8%): 2-5% 3
• Newly diagnosed diabetes: Up to 1% 7
• Diabetes with poor control + obesity + hypertension: Up to 9.3% 5

Clinical implication: The higher the number of Cushing-associated features, the higher the pre-test probability and the more aggressive screening should be.

Treatment Implications

If Cushing Syndrome is Confirmed

Primary treatment: Address the cortisol excess first 1, 8

• Surgical resection (transsphenoidal for pituitary, adrenalectomy for adrenal)
• Medical therapy if surgery contraindicated or unsuccessful
• Diabetes often improves or resolves after successful treatment of hypercortisolism 1, 8

Thromboprophylaxis is critical 1:

• VTE risk is 10-18 fold higher in Cushing patients
• Extend prophylaxis to 30 days post-operatively
• Risk persists even after biochemical remission in early months

If Type 2 Diabetes is Confirmed (Cushing excluded)

Follow standard diabetes management per ADA guidelines 2:

• Lifestyle modification (diet, exercise)
• Metformin as first-line pharmacotherapy
• Add additional agents based on comorbidities and cardiovascular risk
• Target HbA1c individualized but generally <7% for most adults

Common Pitfalls to Avoid

1. Testing during acute illness or poor glycemic control: Wait until HbA1c is optimized and patient is clinically stable before screening for Cushing syndrome 4

2. Assuming obesity alone explains everything: Central obesity with purple striae, proximal myopathy, and easy bruising should trigger Cushing evaluation 1

3. Single abnormal test confirmation: Always confirm with repeat or alternative testing due to high false-positive rate in diabetic patients 5

4. Ignoring cardiovascular risk: Both conditions increase cardiovascular mortality, but Cushing syndrome has 4-16 fold increased standardized mortality ratio that may persist even after remission 1

5. Missing subclinical Cushing syndrome: Patients may have mild hypercortisolism without florid Cushingoid features but still have difficult-to-control diabetes 9

Pathophysiologic Connection

Hypercortisolism causes hyperglycemia through multiple mechanisms 8, 9:

• Increased hepatic gluconeogenesis
• Peripheral insulin resistance in muscle and adipose tissue
• Impaired insulin secretion from pancreatic beta cells
• Increased visceral adiposity
• Disruption of circadian cortisol rhythm leading to sustained hyperinsulinemia

This creates a "reverberating cycle" where hypercortisolism worsens insulin resistance, which further disrupts the hypothalamic-pituitary-adrenal axis 9.

Bottom line: In patients with type 2 diabetes and HbA1c ≥8% despite appropriate therapy, particularly with hypertension, central obesity, and characteristic physical findings, perform 1-mg overnight DST to screen for Cushing syndrome, as 2-5% will have unsuspected hypercortisolism that may improve with definitive treatment 3, 5.